close
This ad will auto close in 10 seconds
Sanofi, Google parent in $500 million diabetes joint venture

Sanofi, Google parent in $500 million diabetes joint venture

French drugmaker Sanofi and Google owner Alphabet`s life sciences firm Verily are to invest about $500 million in a diabetes joint venture combining devices with services, an example of growing ties between the pharma and tech sectors.

Sanofi recalls some batches of painkiller Combiflam in India

Sanofi recalls some batches of painkiller Combiflam in India

Sanofi is recalling some batches of its painkiller Combiflam in India after the country`s drugs regulator found the lots were substandard, the French drugmaker`s local unit said on Thursday.

Sanofi Pasteur launches injectable inactivated polio vaccine

All vaccines (both Imovax Polio of Sanofi Pasteur and ShanIPV of Shantha) would be delivered in India through UNICEF.

Sanofi sells its Andheri building in Mumbai for Rs 111 cr

Sanofi India shares on Friday closed 0.61 percent down at Rs 4,455.85 per scrip on BSE.

CCI imposes Rs 64 crore fine on GlaxoSmithKline, Sanofi

Every year, the government invites tenders for purchase of meningitis vaccine that is required to be administered upon Haj pilgrims.

Sanofi picks 20% stake in Apollo Sugar Clinics for Rs 90 crore

French healthcare major Sanofi is picking up 20 percent stake for Rs 90 crore in Apollo Sugar Clinics, a diabetes care chain of Chennai-based healthcare major Apollo Hospitals.

Sanofi sacks CEO over management row, shares plunge

French drugmaker Sanofi fired its chief executive on Wednesday after a row over his management style, sending the pharmaceutical giant`s shares sharply lower.

Sanofi inks marketing pact with Emcure for cancer drugs

Drug firm Sanofi has entered into a marketing and distribution agreement with Emcure Pharmaceuticals for its oncology portfolio in India.

Sanofi shows profit surge, shares jump

French pharmaceutical giant Sanofi achieved a profits leap in the second quarter of the year and raised its forecast for the year, in a results statement on Thursday which boosted shares.

Sanofi India to double consumer healthcare biz to Rs 1,000 cr

Sanofi India (previously known as Aventis Pharma) Tuesday said it aims to double its consumer healthcare business in the next five years.

LIC trims stake in Tata Global Beverages to 7.63%

LIC sold over 1.28 crore shares, representing around 2.08 percent stake, in the Tata group firm. These scrips were offloaded between August 23 and December 26, 2012, through open market sale, Tata Global Beverages said in a filing to the BSE.

Sanofi India net down 6.38% at Rs 51.3 cr in Jul-Sept

The company had posted a net profit of Rs 54.8 crore for the same quarter last fiscal.